Neurogene
NGNE
NGNE
87 hedge funds and large institutions have $368M invested in Neurogene in 2024 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 30 increasing their positions, 17 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
29.91% less ownership
Funds ownership: 106.6% → 76.69% (-30%)
37% less capital invested
Capital invested by funds: $581M → $368M (-$213M)
44% less call options, than puts
Call options by funds: $3.06M | Put options by funds: $5.52M
Holders
87
Holding in Top 10
2
Calls
$3.06M
Puts
$5.52M
Top Buyers
| 1 | +$17.6M | |
| 2 | +$13.7M | |
| 3 | +$10.9M | |
| 4 |
SB
Samsara BioCapital
Palo Alto,
California
|
+$10.3M |
| 5 |
DM
Deerfield Management
New York
|
+$10.2M |
Top Sellers
| 1 | -$29.8M | |
| 2 | -$17.8M | |
| 3 | -$12.8M | |
| 4 |
SL
Siren LLC
Greenwich,
Connecticut
|
-$7.38M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$5.11M |